BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32621747)

  • 41. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis.
    Caron I; Micotti E; Paladini A; Merlino G; Plebani L; Forloni G; Modo M; Bendotti C
    PLoS One; 2015; 10(7):e0132159. PubMed ID: 26132656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice.
    Ito Y; Yamada M; Tanaka H; Aida K; Tsuruma K; Shimazawa M; Hozumi I; Inuzuka T; Takahashi H; Hara H
    Neurobiol Dis; 2009 Dec; 36(3):470-6. PubMed ID: 19733664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.
    Tortarolo M; Veglianese P; Calvaresi N; Botturi A; Rossi C; Giorgini A; Migheli A; Bendotti C
    Mol Cell Neurosci; 2003 Jun; 23(2):180-92. PubMed ID: 12812752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
    Peviani M; Cheroni C; Troglio F; Quarto M; Pelicci G; Bendotti C
    Mol Cell Neurosci; 2007 Apr; 34(4):592-602. PubMed ID: 17303436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of aromatase expression in the spinal cord of an animal model of familial ALS.
    Sun C; Liu Y; Liu Y; Zhao M; Zhai J; Hao P; Wang Y; Ji Y
    Brain Res Bull; 2017 Jun; 132():180-189. PubMed ID: 28583855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-γ Receptor 1 and GluR1 upregulated in motor neurons of symptomatic hSOD1G93A mice.
    Sengupta S; Le TT; Adam A; Tadić V; Stubendorff B; Keiner S; Kloss L; Prell T; Witte OW; Grosskreutz J
    Eur J Neurosci; 2019 Jan; 49(1):62-78. PubMed ID: 30457201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.
    Gomes C; Cunha C; Nascimento F; Ribeiro JA; Vaz AR; Brites D
    Mol Neurobiol; 2019 Mar; 56(3):2137-2158. PubMed ID: 29995256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system.
    Watanabe S; Ageta-Ishihara N; Nagatsu S; Takao K; Komine O; Endo F; Miyakawa T; Misawa H; Takahashi R; Kinoshita M; Yamanaka K
    Mol Brain; 2014 Aug; 7():62. PubMed ID: 25167838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
    Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
    J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.
    Vallarola A; Tortarolo M; De Gioia R; Iamele L; de Jonge H; de Nola G; Bovio E; Pasetto L; Bonetto V; Freschi M; Bendotti C; Gherardi E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1
    Mitsui S; Otomo A; Nozaki M; Ono S; Sato K; Shirakawa R; Adachi H; Aoki M; Sobue G; Shang HF; Hadano S
    Mol Brain; 2018 May; 11(1):30. PubMed ID: 29843805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS.
    Rabinovich-Nikitin I; Ezra A; Barbiro B; Rabinovich-Toidman P; Solomon B
    J Neuroinflammation; 2016 May; 13(1):123. PubMed ID: 27230771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
    Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
    Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice.
    Mimoto T; Miyazaki K; Morimoto N; Kurata T; Satoh K; Ikeda Y; Abe K
    Brain Res; 2012 Mar; 1446():109-18. PubMed ID: 22353756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential activation of neuronal and glial STAT3 in the spinal cord of the SOD1
    Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
    Eur J Neurosci; 2017 Aug; 46(4):2001-2014. PubMed ID: 28715117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.